Hemolytic transfusion reactions

Rossi’s Principles of Transfusion Medicine

Volumn , Issue , 2016, Pages 642-651

  Davenport, Robertson D ^a   Bluth, Martin H ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alloimmunization; Complement; Cytokines; Hemolysis; Hemovigilance; Phagocytosis; Phenotype matching; Red cell antibodies; Red cell antigens; Red cell compatibility

Indexed keywords

EID: 85045549762     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119013020.ch57     Document Type: Chapter

References (7)

1. Bolton-Maggs PHB (Ed.), Poles D, Watt A, Thomas D on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2013 Annual SHOT Report (2014). http://www.shotuk.org/wp-content/uploads/74280-SHOT-2014-Annual-Report-V12-WEB.pdf
2. Petz LD, Calhoun L, Shulman IA, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382-92.
3. Dzik W, Murphy M, Andreu G, et al. An international study of the performance of sample collection from patients. Vox Sang 2003;85:40-7.
4. Kohan AI, Niborski RC, Rey JA, et al. High-dose intravenous immunoglobulin in non-ABO transfusion incompatibility. Vox Sang 1994;67:195-8.
5. Davenport RD, Burdick M, Moore SA, Kunkel SL. Cytokine production in IgG mediated red cell incompatibility. Transfusion 1993;33:19-24.
6. Callum J, Kaplan H, Merkley L, et al. Reporting of near-miss events for transfusion medicine: Improving transfusion safety. Transfusion 2001;41:1204-11.
7. Schonewille H, van de Watering L, Brand A. Additional red blood cell alloanti- bodies after blood transfusions in a nonhematologic alloimmunized patient cohort:Is it time to take precautionary measures? Transfusion 2006;46:630-5.